New Study Highlights Need for Improved Sepsis Diagnosis and Triage
Cytovale detailed the publication of a new peer-reviewed study that highlights the need for rapid sepsis testing.
Cytovale detailed the publication of a new peer-reviewed study that highlights the need for rapid sepsis testing.
Cytovale announced the U.S. commercial launch of the IntelliSep sepsis test following FDA 510(k) clearance in December 2022.
At the request of IIROC, Asep Medical Holdings clarified its disclosure regarding its diagnostic and therapeutic technologies.
A new test can predict sepsis before blood clots cause organ damage by detecting shifts in blood protein abundance soon after infection.
Read MorePrenosis, Inc.is expanding its existing partnership with Roche Diagnostics that will to improve and expedite the clinical recognition of sepsis.
Read MoreResearchers have developed a new tool that could help provide early warnings of potentially deadly bacterial pathogens which cause sepsis, among other uses.
Read MoreKe Du, PhD, is developing a microfluidic device to improve detection of drug resistant bacteria in blood, one of the most common pathogens causing sepsis.
Read MoreIn screening for sepsis in newborns, there is a need to develop sensitive, and integrated diagnostic strategies to enhance detection.
Read MoreMagnolia Medical Technologies, Inc., announces its new Steripath Micro Initial Specimen Diversion Device designed for children’s hospitals.
Read MoreNanoDx, Inc., has entered into a licensing agreement with IBM Research for use of its nanoscale sensors for accurate, rapid testing.
Read MoreData from a new study published in JAMA Internal Medicine raises red flags surrounding the practice of relying on proprietary algorithms to warn of dangerous conditions, particularly one used to detect sepsis, reports Wired.
Read MoreFindings confirm that T2 Biosystems’ magnetic resonance technology for identification of bloodstream infections provides faster time to detection and shorter hospital stays.
Read MoreT2 Biosystems CEO John Sperzel has released a book about his personal experience with a bloodstream infection and sepsis, titled “Courage: Powerful Lessons in Leadership, Strength, and the Will to Succeed.”
Read MoreThe UT Dallas researchers’ sensor is a portable device that monitors a panel of five immune biomarkers using only a single drop of blood plasma, making a sepsis diagnosis available within minutes.
Read MoreDevice manufacturers that unravel technical and regulatory issues will lead the fight.
Read MoreSustainable harvesting of limulus amebocyte lysate could save hundreds of thousands of horseshoe crabs per year, while offering life-saving clinical uses for humans.
Read MoreThe contract covers the T2Dx instrument as well as the T2Bacteria and T2Candida panels, which detect sepsis-causing bacterial and fungal pathogens directly from whole blood.
Read MoreSperzel succeeds John McDonough, who will continue with his board leadership role, serving as nonexecutive chairman.
Read More